Triple

Target class: catechol-O-methyltransferase inhibitor
Context triple: [entacapone, instanceOf, catechol-O-methyltransferase inhibitor]

• A. aromatic L-amino acid decarboxylase inhibitor
  An aromatic L-amino acid decarboxylase inhibitor is a drug that blocks the enzyme responsible for converting aromatic L-amino acids (like levodopa) into their corresponding neurotransmitters, thereby increasing the availability of these precursors for therapeutic use, particularly in Parkinson’s disease.
• B. dopamine receptor antagonist
  A dopamine receptor antagonist is a drug that binds to dopamine receptors without activating them, thereby blocking dopamine’s effects and modulating neural signaling in conditions such as psychosis, nausea, and movement disorders.
• C. cholinesterase inhibitor
  A cholinesterase inhibitor is a substance that prevents the breakdown of the neurotransmitter acetylcholine by inhibiting cholinesterase enzymes, thereby enhancing cholinergic signaling in the nervous system.
• D. cytochrome P450 enzyme
  A cytochrome P450 enzyme is a heme-containing monooxygenase that catalyzes the oxidation of a wide variety of endogenous and exogenous substrates, playing key roles in metabolism, detoxification, and biosynthesis.
• E. glutamate release inhibitor
  A glutamate release inhibitor is an agent that reduces the presynaptic release of the excitatory neurotransmitter glutamate, thereby modulating neuronal excitability and protecting against excitotoxicity.
• F. None of above. chosen